Skip to main content
SpringerLink
Log in

Cytogenetics of Solid Tumors

  • Chapter
The Principles of Clinical Cytogenetics

Abstract

The field of cytogenetics has had a great impact on clinical and basic sciences in hematology and oncology, and both karyotyping and fluorescence in situ hybridization (FISH) assays are of growing relevance in solid tumor oncology. Although most of the cancer cytogenetic work in clinical laboratories is directed to hematological disorders, it is increasingly evident that cytogenetic assays are essential in providing diagnostic or prognostic information for various solid tumors (see Tables 1 and 2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sreekantaiah, C., Appaji, L., and Hazarika, D. (1992) Cytogenetic characterisation of small round cell tumours using fine needle aspiration. J. Clin. Pathol. 45, 728–730.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Akerman, M., Dreinhofer, K., Rydholm, A., et al. (1996) Cytogenetic studies on fine-needle aspiration samples from osteosarcoma and Ewing’s sarcoma. Diagn. Cytopathol. 15, 17–22.

    CAS  PubMed  Google Scholar 

  3. Hoffer, F.A., Gianturco, L.E., Fletcher, J.A., and Grier, H.E. (1994) Percutaneous biopsy of peripheral primitive neuroectodermal tumors and Ewing’s sarcomas for cytogenetic analysis. Am. J. Roentgenol. 162, 1141–1142.

    CAS  Google Scholar 

  4. Saboorian, M.H., Ashfaq, R., Vandersteenhoven, J.J., and Schneider, N.R. (1997) Cytogenetics as an adjunct in establishing a definitive diagnosis of synovial sarcoma by fine-needle aspiration. Cancer 81, 187–192.

    CAS  PubMed  Google Scholar 

  5. Cajulis, R.S. and Frias-Hidvegi, D. (1993) Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes. Acta Cytol. 37, 391–396.

    CAS  PubMed  Google Scholar 

  6. Cajulis, R.S., Kotliar, S., Haines, G.K., Frias-Hidvegi, D., and O’Gorman, M. (1994) Comparative study of interphase cytogenetics, flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma. Diagn. Cytopathol. 11, 151–158.

    CAS  PubMed  Google Scholar 

  7. Limon, J., Dal Cin, P., and Sandberg, A.A. (1986) Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet. Cytogenet. 23, 305–313.

    CAS  PubMed  Google Scholar 

  8. Ried, T. (1998) Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am. J. Pathol. 152, 325–327.

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Hsi, B.L., Xiao, S., and Fletcher, J.A. (2002) Chromogenic in situ hybridization and FISH in pathology. Methods Mol. Biol. 204, 343–351.

    CAS  PubMed  Google Scholar 

  10. Hopman, A.H., Claessen, S., and Speel, E.J. (1997) Multi-colour brightfield in situ hybridisation on tissue sections. Histochem. Cell Biol. 108, 291–298.

    CAS  PubMed  Google Scholar 

  11. Speel, E.J., Ramaekers, F.C., and Hopman, A.H. (1995) Cytochemical detection systems for in situ hybridization, and the combination with immunocytochemistry, “who is still afraid of red, green and blue?” J. Histochem. 27, 833–858.

    CAS  Google Scholar 

  12. Liu, E., Thor, A., He, M., Barcos, M., Ljung, B.M., and Benz, C. (1992) The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7, 1027–1032.

    CAS  PubMed  Google Scholar 

  13. Ross, J.S., Fletcher, J.A., Linette, G.P., et al. (2003) The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist. 8, 307–325.

    CAS  PubMed  Google Scholar 

  14. Kim, S.Y., Lee, J.S., Ro, J.Y., Gay, M.L., Hong, W.K., and Hittelman, W.N. (1993) Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity. Am. J. Pathol. 142, 307–317.

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Schofield, D.E. and Fletcher, J.A. (1992) Trisomy 12 in pediatric granulosa-stromal cell tumors. Demonstration by a modified method of fluorescence in situ hybridization on paraffin-embedded material. Am. J. Pathol. 141, 1265–1269.

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Paternoster, S.F., Brockman, S.R., McClure, R.F., Remstein, E.D., Kurtin, P.J., and Dewald, G.W. (2002) A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am. J. Pathol. 160, 1967–1972.

    CAS  PubMed Central  PubMed  Google Scholar 

  17. Kallioniemi, A., Kallioniemi, O.P., Sudar, D., et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818–821.

    CAS  PubMed  Google Scholar 

  18. Albertson, D.G., Ylstra, B., Segraves, R., et al. (2000) Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 25, 144–146.

    CAS  PubMed  Google Scholar 

  19. Schrock, E., du Manoir, S., Veldman, T., Nat. Genet. (1996) Multicolor spectral karyotyping of human chromosomes. Science 273, 494–497.

    CAS  PubMed  Google Scholar 

  20. Veldman, T., Vignon, C., Schrock, E., Rowley, J.D., and Ried, T. (1997) Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nature Genet. 15, 406–410.

    CAS  PubMed  Google Scholar 

  21. Macville, M., Schrock, E., Padilla-Nash, H., Nat. Genet. (1999) Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 59, 141–150.

    CAS  PubMed  Google Scholar 

  22. Mackall, C.L., Meltzer, P.S., and Helman, L.J. (2002) Focus on sarcomas. Cancer Cell 2, 175–178.

    CAS  PubMed  Google Scholar 

  23. Oliveira, A.M. and Fletcher, J.A. (2002) Translocation breakpoints in cancer. In Encyclopedia of the Human Genome Nature. Publishing, London, U.K.

    Google Scholar 

  24. Look, A.T., Hayes, F.A., Shuster, J.J., et al. (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J. Clin. Oncol. 9, 581–591.

    CAS  PubMed  Google Scholar 

  25. Delattre, O., Zucman, J., Plougastel, B., et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162–165.

    CAS  PubMed  Google Scholar 

  26. Turc-Carel, C., Philip, I., Berger, M. P., Philip, T., and Lenoir, G. M. (1984) Chromosome study of Ewing’s sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Genet. Cytogenet. 12, 1–19.

    CAS  PubMed  Google Scholar 

  27. Turc-Carel, C., Aurias, A., Mugneret, F., et al. (1988) Chromosomes in Ewing’s sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 32, 229–238.

    CAS  PubMed  Google Scholar 

  28. Ewen, M.E., Ludlow, J.W., Marsilio, E., et al. (1989) An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell 58, 257–267.

    CAS  PubMed  Google Scholar 

  29. Buckler, A.J., Chang, D.D., Graw, S.L., et al. (1991) Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proc. Natl. Acad. Sci. USA 88, 4005–4009.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Jeon, I.S., Davis, J.N., Braun, B.S., et al. (1995) A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10, 1229–1234.

    CAS  PubMed  Google Scholar 

  31. Peter, M., Couturier, J., Pacquement, H., et al. (1997) A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14, 1159–1164.

    CAS  PubMed  Google Scholar 

  32. Kaneko, Y., Yoshida, K., Handa, M., et al. (1996) Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 15, 115–121.

    CAS  PubMed  Google Scholar 

  33. Ishida, S., Yoshida, K., Kaneko, Y., et al. (1998).The genomic breakpoint and chimeric transcripts in the EWSR1-ETV4/E1AF gene fusion in Ewing sarcoma. Cytogenet. Cell Genet. 82, 278–283.

    CAS  PubMed  Google Scholar 

  34. Desmaze, C., Zucman, J., Delattre, O., Melot, T., Thomas, G., and Aurias, A. (1994) Interphase molecular cytogenetics of Ewing’s sarcoma and peripheral neuroepithelioma t(11;22) with flanking and overlapping cosmid probes. Cancer Genet. Cytogenet. 74, 13–18.

    CAS  PubMed  Google Scholar 

  35. Barr, F.G., Chatten, J., D’Cruz, C.M., et al. (1995) Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 273, 553–557.

    CAS  PubMed  Google Scholar 

  36. Zoubek, A., Dockhorn-Dworniczak, B., Delattre, O., et al. (1996) Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14, 1245–1251.

    CAS  PubMed  Google Scholar 

  37. de Alava, E., Kawai, A., Healey, J.H., et al. (1998) EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J. Clin. Oncol. 16, 1248–1255.

    PubMed  Google Scholar 

  38. Fletcher, J. A. (1998) Ewing’s sarcoma oncogene structure: a novel prognostic marker? J. Clin. Oncol. 16, 1241–1243.

    CAS  PubMed  Google Scholar 

  39. Davison, J.M., Morgan, T.W., Hsi, B.L., Xiao, S., and Fletcher, J. A. (1998) Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications. Am. J. Pathol. 153, 1401–1409.

    CAS  PubMed Central  PubMed  Google Scholar 

  40. Galili, N., Davis, R.J., Fredericks, W.J., et al. (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet. 5, 230–235.

    CAS  PubMed  Google Scholar 

  41. Barr, F.G., Galili, N., Holick, J., Biegel, J.A., Rovera, G., and Emanuel, B. S. (1993) Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet. 3, 113–117.

    CAS  PubMed  Google Scholar 

  42. Shapiro, D.N., Sublett, J.E., Li, B., Downing, J.R., and Naeve, C.W. (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 5108–5112.

    CAS  PubMed  Google Scholar 

  43. Davis, R.J., D’Cruz, C.M., Lovell, M.A., Biegel, J.A., and Barr, F.G. (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54, 2869–2872.

    CAS  PubMed  Google Scholar 

  44. Davis, R.J., and Barr, F.G. (1997) Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 94, 8047–8051.

    CAS  PubMed Central  PubMed  Google Scholar 

  45. Fredericks, W.J., Galili, N., Mukhopadhyay, S., et al. (1995) The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell Biol. 15, 1522–1535.

    CAS  PubMed Central  PubMed  Google Scholar 

  46. Bennicelli, J.L., Fredericks, W.J., Wilson, R.B., Rauscher, F.J. 3rd, and Barr, F.G. (1995) Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11, 119–130.

    CAS  PubMed  Google Scholar 

  47. Turc-Carel, C., Dal Cin, P., Limon, J., et al. (1987) Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc. Natl. Acad. Sci. USA 84, 1981–1985.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Limon, J., Mrozek, K., Mandahl, N., et al. (1991) Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 3, 338–345.

    CAS  PubMed  Google Scholar 

  49. Clark, J., Rocques, P.J., Crew, A.J., et al. (1994) Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nature Genet. 7, 502–508.

    CAS  PubMed  Google Scholar 

  50. Janz, M., de Leeuw, B., Weghuis, D.O., et al. (1995) Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J. Pathol. 175, 391–396.

    CAS  PubMed  Google Scholar 

  51. Shipley, J.M., Clark, J., Crew, A.J., et al. (1994) The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 9, 1447–1453.

    CAS  PubMed  Google Scholar 

  52. Kawai, A., Woodruff, J., Healey, J.H., Brennan, M.F., Antonescu, C.R., and Ladanyi, M. (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N. Engl. J. Med. 338, 153–160.

    CAS  PubMed  Google Scholar 

  53. Sreekantaiah, C., Leong, S.P., Karakousis, C.P., et al. (1991) Cytogenetic profile of 109 lipomas. Cancer Res. 51, 422–433.

    CAS  PubMed  Google Scholar 

  54. Mandahl, N., Hoglund, M., Mertens, F., et al. (1994) Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 9, 207–215.

    CAS  PubMed  Google Scholar 

  55. Fletcher, C.D., Akerman, M., Dal Cin, P., et al. (1996) Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am. J. Pathol. 148, 623–630.

    CAS  PubMed Central  PubMed  Google Scholar 

  56. Ashar, H.R., Fejzo, M.S., Tkachenko, A., et al. (1995) Disruption of the architectural factor HMGI-C: DNA-binding A-T hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82, 57–65.

    CAS  PubMed  Google Scholar 

  57. Mandahl, N., Mertens, F., Willen, H., Rydholm, A., Brosjo, O., and Mitelman, F. (1994) A new cytogenetic subgroup in lipomas: loss of chromosome 16 material in spindle cell and pleomorphic lipomas. J. Cancer Res. Clin. Oncol. 120, 707–711.

    CAS  PubMed  Google Scholar 

  58. Hibbard, M.K., Kozakewich, H.P., Dal Cin, P., et al. (2000) PLAG1 fusion oncogenes in lipoblastoma. Cancer Res. 60, 4869–4872.

    CAS  PubMed  Google Scholar 

  59. Mrozek, K., Karakousis, C.P., and Bloomfield, C.D. Band 11q13 is nonrandomly rearranged in hibernomas. (1994) Genes Chromosomes Cancer 9, 145–147.

    CAS  PubMed  Google Scholar 

  60. Turc-Carel, C., Limon, J., Dal Cin, P., Rao, U., Karakousis, C., and Sandberg, A.A. (1986) Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet. Cytogenet. 23, 291–299.

    CAS  PubMed  Google Scholar 

  61. Sreekantaiah, C., Karakousis, C.P., Leong, S.P., and Sandberg, A.A. (1992) Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer 69, 2484–2495.

    CAS  PubMed  Google Scholar 

  62. Hisaoka, M., Tsuji, S., Morimitsu, Y., et al. (1998) Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Diagn. Mol. Pathol. 7, 96–101.

    CAS  PubMed  Google Scholar 

  63. Kuroda, M., Ishida, T., Horiuchi, H., et al. (1995) Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am. J. Pathol. 147, 1221–1227.

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Aman, P., Ron, D., Mandahl, N., et al. (1992) Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 5, 278–285.

    CAS  PubMed  Google Scholar 

  65. Crozat, A., Aman, P., Mandahl, N., and Ron, D. (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640–644.

    CAS  PubMed  Google Scholar 

  66. Mandahl, N., Heim, S., Arheden, K., Rydholm, A., Willen, H., and Mitelman, F. (1988) Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet. Cytogenet. 30, 23–33.

    CAS  PubMed  Google Scholar 

  67. Turc-Carel, C., Dal Cin, P., Rao, U., Karakousis, C., and Sandberg, A.A. (1988) Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Cancer Genet. Cytogenet. 30, 145–150.

    CAS  PubMed  Google Scholar 

  68. Pedeutour, F., Forus, A., Coindre, J.M., et al. (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24, 30–41.

    CAS  PubMed  Google Scholar 

  69. Zucman, J., Delattre, O., Desmaze, C., et al. (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet. 4, 341–345.

    CAS  PubMed  Google Scholar 

  70. Brown, A.D., Lopez-Terrada, D., Denny, C., and Lee, K. A. (1995) Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. Oncogene 10, 1749–1756.

    CAS  PubMed  Google Scholar 

  71. Gerald, W.L., Miller, H.K., Battifora, H., Miettinen, M., Silva, E.G., and Rosai, J. (1991) Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am. J. Surg. Pathol. 15, 499–513.

    CAS  PubMed  Google Scholar 

  72. Ladanyi, M. and Gerald, W. (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 54, 2837–2840.

    CAS  PubMed  Google Scholar 

  73. Gerald, W.L., Ladanyi, M., de Alava, E., et al. (1998) Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J. Clin. Oncol. 16, 3028–3036.

    CAS  PubMed  Google Scholar 

  74. Rodriguez, E., Sreekantaiah, C., Gerald, W., Reuter, V.E., Motzer, R.J., and Chaganti, R.S. (1993) recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet. Cytogenet. 69, 17–21.

    CAS  PubMed  Google Scholar 

  75. Biegel, J.A., Conard, K., and Brooks, J.J. (1993) Translocation (11;22)(p13;q12): primary change in intra-abdominal desmoplastic small round cell tumor. Genes Chromosomes Cancer 7, 119–121.

    CAS  PubMed  Google Scholar 

  76. Lee, S.B., Kolquist, K.A., Nichols, K., et al. (1997) The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nature Genet. 17, 309–313.

    CAS  PubMed  Google Scholar 

  77. Kelly, J.D., Haldeman, B.A., Grant, F.J., et al. (1991) Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J. Biol. Chem. 266, 8987–8992.

    CAS  PubMed  Google Scholar 

  78. Pedeutour, F., Simon, M.P., Minoletti, F., et al. (1995) Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences. Cancer Res. 55, 2400–2403.

    CAS  PubMed  Google Scholar 

  79. Naeem, R., Lux, M.L., Huang, S.F., Naber, S.P., Corson, J.M., and Fletcher, J.A. (1995) Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am. J. Pathol. 147, 1553–1558.

    CAS  PubMed Central  PubMed  Google Scholar 

  80. Simon, M.P., Pedeutour, F., Sirvent, N., et al. (1997) Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nature Genet. 15, 95–98.

    CAS  PubMed  Google Scholar 

  81. O’Brien, K.P., Seroussi, E., Dal Cin, P., et al. (1998) Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23, 187–193.

    PubMed  Google Scholar 

  82. Maki, R.G., Awan, R.A., Dixon, R.H., Jhanwar, S., and Antonescu, C.R. (2002) Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int. J. Cancer 100, 623–626.

    CAS  PubMed  Google Scholar 

  83. Rubin, B.P., Schuetze, S.M., Eary, J.F., et al. (2002) Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J. Clin. Oncol. 20, 3586–3591.

    CAS  PubMed  Google Scholar 

  84. Alman, B.A., Li, C., Pajerski, M.E., Diaz-Cano, S., and Wolfe, H.J. (1997) Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am. J. Pathol. 151, 329–334.

    CAS  PubMed Central  PubMed  Google Scholar 

  85. Tejpar, S., Nollet, F., Li, C., et al. (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18, 6615–6620.

    CAS  PubMed  Google Scholar 

  86. Fletcher, J.A., Naeem, R., Xiao, S., and Corson, J.M. (1995) Chromosome aberrations in desmoid tumors. Trisomy 8 might be a predictor of recurrence. Cancer Genet. Cytogenet. 79, 139–143.

    CAS  PubMed  Google Scholar 

  87. Miyaki, M., Konishi, M., Kikuchi-Yanoshita, R., et al. (1993) Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res. 53, 5079–5082.

    CAS  PubMed  Google Scholar 

  88. Sen-Gupta, S., Van der Luijt, R.B., Bowles, L.V., Meera Khan, P., and Delhanty, J.D. (1993) Somatic mutation of APC gene in desmoid tumour in familial adenomatous polyposis. Lancet 342, 552–553.

    CAS  PubMed  Google Scholar 

  89. Schofield, D.E., Fletcher, J.A., Grier, H.E., and Yunis, E.J. (1994) Fibrosarcoma in infants and children. Application of new techniques. Am. J. Surg. Pathol. 18, 14–24.

    CAS  PubMed  Google Scholar 

  90. Schofield, D.E., Yunis, E.J., and Fletcher, J.A. (1993) Chromosome aberrations in mesoblastic nephroma. Am. J. Pathol. 143,714–724.

    CAS  PubMed Central  PubMed  Google Scholar 

  91. Knezevich, S.R., McFadden, D.E., Tao, W., Lim, J.F. and Sorensen, P.H. (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nature Genet. 18, 184–187.

    CAS  PubMed  Google Scholar 

  92. Rubin, B.P., Chen, C.J., Morgan, T.W., et al. (1998) Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am. J. Pathol. 153, 1451–1458.

    CAS  PubMed Central  PubMed  Google Scholar 

  93. Knezevich, S.R., Garnett, M.J., Pysher, T.J., Beckwith, J.B., Grundy, P.E., and Sorensen, P.H. (1998) ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 58, 5046–5048.

    CAS  PubMed  Google Scholar 

  94. Treissman, S.P., Gillis, D.A., Lee, C.L., Giacomantonio, M., and Resch, L. (1994) Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor. Cancer 73, 1433–1437.

    CAS  PubMed  Google Scholar 

  95. Snyder, C.S., Dell’Aquila, M., Haghighi, P., Baergen, R.N., Suh, Y.K., and Yi, E.S. (1995) Clonal changes in inflammatory pseudotumor of the lung: a case report. Cancer 76, 1545–1549.

    CAS  PubMed  Google Scholar 

  96. Su, L.D., Atayde-Perez, A., Sheldon, S., Fletcher, J.A., and Weiss, S.W. (1998) Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod. Pathol. 11, 364–368.

    CAS  PubMed  Google Scholar 

  97. Lawrence, B., Perez-Atayde, A., Hibbard, M.K., et al. (2000) TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am. J. Pathol. 157, 377–384.

    CAS  PubMed Central  PubMed  Google Scholar 

  98. Hirota, S., Isozaki, K., Moriyama, Y., et al. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577–580.

    CAS  PubMed  Google Scholar 

  99. Rubin, B.P., Singer, S., Tsao, C., et al. (2001) KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 61, 8118–8121.

    CAS  PubMed  Google Scholar 

  100. Heinrich, M.C., Corless, C.L., Duensing, A., et al. (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299, 708–710.

    CAS  PubMed  Google Scholar 

  101. Demetri, G.D., von Mehren, M., Blanke, C.D., et al. (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347, 472–480.

    CAS  PubMed  Google Scholar 

  102. van Oosterom, A.T., Judson, I., Verweij, J., et al. (2001) Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358, 1421–1423.

    PubMed  Google Scholar 

  103. Nishida, T., Hirota, S., Taniguchi, M., et al. (1998) Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nature Genet. 19, 323–324.

    CAS  PubMed  Google Scholar 

  104. Sarlomo-Rikala, M., el-Rifai, W., Lahtinen, T., Andersson, L.C., Miettinen, M., and Knuutila, S. (1998) Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum. Pathol. 29, 476–481.

    CAS  PubMed  Google Scholar 

  105. el Rifai, W., Sarlomo-Rikala, M., Andersson, L.C., Knuutila, S., and Miettinen, M. (2000) DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 60, 3899–3903.

    PubMed  Google Scholar 

  106. Schneider-Stock, R., Boltze, C., Lasota, J., et al. (2003) High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J. Clin. Oncol. 21, 1688–1697.

    CAS  PubMed  Google Scholar 

  107. Legius, E., Marchuk, D.A., Collins, F.S., and Glover, T.W. (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genet. 3, 122–126.

    CAS  PubMed  Google Scholar 

  108. Basu, T.N., Gutmann, D.H., Fletcher, J.A., Glover, T.W., Collins, F.S., and Downward, J. (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713–715.

    CAS  PubMed  Google Scholar 

  109. DeClue, J.E., Papageorge, A.G., Fletcher, J.A., et al. (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69, 265–273.

    CAS  PubMed  Google Scholar 

  110. Rouleau, G.A., Merel, P., Lutchman, M., et al. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363, 515–521.

    CAS  PubMed  Google Scholar 

  111. Twist, E.C., Ruttledge, M.H., Rousseau, M., et al. (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum. Mol. Genet. 3, 147–151.

    CAS  PubMed  Google Scholar 

  112. Lutchman, M. and Rouleau, G.A. (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res. 55, 2270–2274.

    CAS  PubMed  Google Scholar 

  113. Kluwe, L., Friedrich, R., and Mautner, V.-F. (1999) Loss of NF1 allele in Schwann cells but not in fibroblasts dervied from an NF1-associated neurofibroma. Genes Chromosomes Cancer 24, 283–285.

    CAS  PubMed  Google Scholar 

  114. Murthy, S.S. and Testa, J.R. (1999) Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J. Cell Physiol. 180, 150–157.

    CAS  PubMed  Google Scholar 

  115. Lechner, J.F., Tokiwa, T., LaVeck, M., et al. (1985) Asbestos-associated chromosomal changes in human mesothelial cells. Proc. Natl. Acad. Sci. USA 82, 3884–3888.

    CAS  PubMed Central  PubMed  Google Scholar 

  116. Ault, J.G., Cole, R.W., Jensen, C.G., Jensen, L.C.W., Bachert, L.A., and Rieder, C.L. (1995) Behavior of crocidolite asbestos during mitosis in living vertebrate lung epithelial cells. Cancer Res. 55, 792–798.

    CAS  PubMed  Google Scholar 

  117. Hayashi, Y., Inaba, T., Hanada, R., and Yamamoto, K. (1988) Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening. J. Pediatr. 112, 567–571.

    CAS  PubMed  Google Scholar 

  118. Brodeur, G.M., Azar, C., Brother, M., et al. (1992) Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer 70, 1685–1694.

    CAS  PubMed  Google Scholar 

  119. Shapiro, D.N., Valentine, M.B., Rowe, S.T., et al. (1993) Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am. J. Pathol. 142, 1339–1346.

    CAS  PubMed Central  PubMed  Google Scholar 

  120. Komuro, H., Valentine, M.B., Rowe, S.T., et al. (1998) Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma. J. Pediatr. Surg. 33, 1695–1698.

    CAS  PubMed  Google Scholar 

  121. Versteege, I., Sevenet, N., Lange, J., et al. (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206.

    CAS  PubMed  Google Scholar 

  122. Biegel, J.A., Zhou, J.Y., Rorke, L.B., Stenstrom, C., Wainwright, L.M., and Fogelgren, B. (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59, 74–79.

    CAS  PubMed  Google Scholar 

  123. Sevenet, N., Sheridan, E., Amram, D., Schneider, P., Handgretinger, R., and Delattre, O. (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am. J. Hum. Genet. 65, 1342–1348.

    CAS  PubMed Central  PubMed  Google Scholar 

  124. Roberts, C.W., Galusha, S.A., McMenamin, M.E., Fletcher, C.D., and Orkin, S.H. (2000) Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc. Natl. Acad. Sci. USA 97, 13,796–13,800.

    CAS  PubMed Central  PubMed  Google Scholar 

  125. Sreekantaiah, C., Davis, J.R., and Sandberg, A.A. (1993) Chromosomal abnormalities in leiomyosarcomas. Am. J. Pathol. 142, 293–305.

    CAS  PubMed Central  PubMed  Google Scholar 

  126. Mitelman, F. (1998) Catalog of Chromosome Aberrations in Cancer 1998, 6th ed. Wiley-Liss, New York

    Google Scholar 

  127. Fletcher, J.A., Morton, C.C., Pavelka, K., and Lage, J.M. (1990) Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Cancer Res. 50, 4092–4097.

    CAS  PubMed  Google Scholar 

  128. Nibert, M. and Heim, S. (1990) Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 2, 3–13.

    CAS  PubMed  Google Scholar 

  129. Nilbert, M., Heim, S., Mandahl, N., Floderus, U.M., Willen, H., and Mitelman, F. (1990) Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup. Cancer Genet. Cytogenet. 45, 63–66.

    CAS  PubMed  Google Scholar 

  130. Xing, Y.P., Powell, W.L., and Morton, C.C. (1997) The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Cancer Genet. Cytogenet. 98, 69–74.

    CAS  PubMed  Google Scholar 

  131. Schoenmakers, E.F., Huysmans, C., and van de Ven, W. J. (1999) Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res. 59, 19–23.

    CAS  PubMed  Google Scholar 

  132. Kovacs, G. and Frisch, S. (1989) Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res. 49, 651–659.

    CAS  PubMed  Google Scholar 

  133. Yamakawa, K., Morita, R., Takahashi, E., Hori, T., Ishikawa, J., and Nakamura, Y. (1991) A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res. 51, 4707–4711.

    CAS  PubMed  Google Scholar 

  134. Presti, J.C., Jr., Rao, P.H., Chen, Q., et al. (1991) Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res. 51, 1544–1552.

    PubMed  Google Scholar 

  135. Kovacs, G. (1989) Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am. J. Pathol. 134, 27–34.

    CAS  PubMed Central  PubMed  Google Scholar 

  136. Kaneko, Y., Homma, C., Maseki, N., Sakurai, M., and Hata, J. (1991) Correlation of chromosome abnormalities with histological and clinical features in Wilms’ and other childhood renal tumors. Cancer Res. 51, 5937–5942.

    CAS  PubMed  Google Scholar 

  137. Grundy, P.E., Telzerow, P.E., Breslow, N., Moksness, J., Huff, V., and Paterson, M.C. (1994) Loss of heterozygosity for chromosomes 16q and 1p in Wilms’ tumors predicts an adverse outcome. Cancer Res. 54, 2331–2333.

    CAS  PubMed  Google Scholar 

  138. Fromowitz, F.B. and Bard, R. H. (1980) Clinical implications of pathologic subtypes in renal cell carcinoma. Semin. Urol. 8, 31–50.

    Google Scholar 

  139. Presti, J.C., Jr., Reuter, V.E., Cordon-Cardo, C., Mazumdar, M., Fair, W.R., and Jhanwar, S. C. (1993) Allelic deletions in renal tumors: histopathological correlations. Cancer Res. 53, 5780–5783.

    CAS  PubMed  Google Scholar 

  140. Latif, F., Tory, K., Gnarra, J., et al. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317–1320.

    CAS  PubMed  Google Scholar 

  141. Whaley, J.M., Naglich, J., Gelbert, L., et al. (1994) Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55, 1092–1102.

    CAS  PubMed Central  PubMed  Google Scholar 

  142. Shuin, T., Kondo, K., Torigoe, S., et al. (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 54, 2852–2855.

    CAS  PubMed  Google Scholar 

  143. Ohta, M., Inoue, H., Cotticelli, M.G., et al. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587–597.

    CAS  PubMed  Google Scholar 

  144. LaForgia, S., Lasota, J., Latif, F., et al. (1993) Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1). Cancer Res. 53, 3118–3124.

    CAS  PubMed  Google Scholar 

  145. Limon, J., Mrozek, K., Heim, S., et al. (1990) On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma. Cancer Genet. Cytogenet. 49, 259–263.

    CAS  PubMed  Google Scholar 

  146. Emanuel, A., Szucs, S., Weier, H.U., and Kovacs, G. (1992) Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosomes Cancer 4, 75–77.

    CAS  PubMed  Google Scholar 

  147. Dal Cin, P., Aly, M.S., Delabie, J., et al. (1992) Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. Proc. Natl. Acad. Sci. USA 89, 9744–9748.

    Google Scholar 

  148. Crotty, T.B., Farrow, G.M., and Lieber, M.M. (1995) Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J. Urol. 154, 964–967.

    CAS  PubMed  Google Scholar 

  149. Speicher, M.R., Schoell, B., du Manoir, S., et al. (1994) Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am. J. Pathol. 145, 356–364.

    CAS  PubMed Central  PubMed  Google Scholar 

  150. Kovacs, G., Fuzesi, L., Emanual, A., and Kung, H. F. (1991) Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3, 249–255.

    CAS  PubMed  Google Scholar 

  151. Renshaw, A.A., Zhang, H., Corless, C.L., Fletcher, J.A., and Pins, M.R. (1997) Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am. J. Surg. Pathol. 21, 1203–1209.

    CAS  PubMed  Google Scholar 

  152. Brown, J.A., Anderl, K.L., Borell, T.J., Qian, J., Bostwick, D.G., and Jenkins, R.B. (1997) Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J. Urol. 158, 370–374.

    CAS  PubMed  Google Scholar 

  153. Kovacs, G. (1993) Molecular differential pathology of renal cell tumours. Histopathology 22, 1–8.

    CAS  PubMed  Google Scholar 

  154. Mancilla-Jimenez, R., Stanley, R.J., and Blath, R.A. (1976) Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 38, 2469–2480.

    CAS  PubMed  Google Scholar 

  155. Corless, C.L., Aburatani, H., Fletcher, J.A., Housman, D.E., Amin, M.B., and Weinberg, D.S. (1996) Papillary renal cell carcinoma: Quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn. Mol. Pathol. 5(1), 53–64.

    CAS  PubMed  Google Scholar 

  156. Corless, C.L., Aburatani, H., Fletcher, J.A., Housman, D.E., Amin, M.B., and Weinberg, D.S. (1996) Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn. Mol. Pathol. 5, 53–64.

    CAS  PubMed  Google Scholar 

  157. Meloni, A.M., Dobbs, R.M., Pontes, J.E., and Sandberg, A.A. (1993) Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet. Cytogenet. 65, 1–6.

    CAS  PubMed  Google Scholar 

  158. Argani, P., Antonescu, C.R., Illei, P.B., et al. (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am. J. Pathol. 159, 179–192.

    CAS  PubMed Central  PubMed  Google Scholar 

  159. Davis, I.J., Hsi, B.L., Arroyo, J.D., et al. (2003) Cloning of an alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc. Natl. Acad. Sci. USA 100, 6051–6056.

    CAS  PubMed Central  PubMed  Google Scholar 

  160. Brown, J.A., Takahashi, S., Alcaraz, A., et al. (1996) Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. J. Urol. 156, 31–35.

    CAS  PubMed  Google Scholar 

  161. van den Berg, E., Dijkhuizen, T., Storkel, S., et al. (1995) Chromosomal changes in renal oncocytomas. Evidence that t(5;11)(q35;q13) might characterize a second subgroup of oncocytomas. Cancer Genet. Cytogenet. 79, 164–168.

    PubMed  Google Scholar 

  162. Fuzesi, L., Gunawan, B., Braun, S., and Boeckmann, W. (1994) Renal oncocytoma with a translocation t(9;11)(p23;q13). J. Urol. 152, 471–472.

    CAS  PubMed  Google Scholar 

  163. Crotty, T.B., Lawrence, K.M., Moertel, C.A., et al. (1992) Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that −Y,−1 might be a characteristic anomaly in renal oncocytomas. Cancer Genet. Cytogenet. 61, 61–66.

    CAS  PubMed  Google Scholar 

  164. Meloni, A.M., Sandberg, A.A., and White, R.D. (1992) −Y,−1 as recurrent anomaly in oncocytoma. Cancer Genet. Cytogenet. 61, 108–109.

    CAS  PubMed  Google Scholar 

  165. Weremowicz, S., Kozakewich, H.P., Haber, D., Park, S., Morton, C.C., and Fletcher, J.A. (1994) Identification of genetically aberrant cell lineages in Wilms’ tumors. Genes Chromosomes Cancer 10, 40–48.

    CAS  PubMed  Google Scholar 

  166. Solis, V., Pritchard, J., and Cowell, J.K. (1988) Cytogenetic changes in Wilms’ tumors. Cancer Genet. Cytogenet. 34, 223–234.

    CAS  PubMed  Google Scholar 

  167. Slater, R.M. and Mannens, M.M. (1992) Cytogenetics and molecular genetics of Wilms’ tumor of childhood. Cancer Genet. Cytogenet. 61, 111–121.

    CAS  PubMed  Google Scholar 

  168. Haber, D.A., Buckler, A.J., Glaser, T., et al. (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms’ tumor. Cell 61, 1257–1269.

    CAS  PubMed  Google Scholar 

  169. Bruening, W., Bardeesy, N., Silverman, B.L., et al. (1992) Germline intronic and exonic mutations in the Wilms’ tumour gene (WT1) affecting urogenital development. Nature Genet. 1, 144–148.

    CAS  PubMed  Google Scholar 

  170. Ton, C.C., Hirvonen, H., Miwa, H., et al. (1991) Positional cloning and characterization of a paired box-and homeobox-containing gene from the aniridia region. Cell 67, 1059–1074.

    CAS  PubMed  Google Scholar 

  171. Douglass, E.C., Look, A.T., Webber, B., Parham, D., Wilimas, J.A., Green, A.A., and Roberson, P.K. (1986) Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms’ tumor. J. Clin. Oncol. 4, 975–981.

    CAS  PubMed  Google Scholar 

  172. Bardeesy, N., Falkoff, D., Petruzzi, M.J., et al. (1994) Anaplastic Wilms’ tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genet. 7, 91–97.

    CAS  PubMed  Google Scholar 

  173. Bolande, R.P., Brough, A.J., and Izant, R.J. Jr. (1967) Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms’ tumor. Pediatrics 40, 272–278.

    CAS  PubMed  Google Scholar 

  174. Pettinato, G., Manivel, J.C., Wick, M.R., and Dehner, L P.(1989) Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. Hum. Pathol. 20, 682–690.

    CAS  PubMed  Google Scholar 

  175. Mascarello, J.T., Cajulis, T.R., Krous, H.F., and Carpenter, P.M. (1994) Presence or absence of trisomy 11 is correlated with histologic subtype in congenital mesoblastic nephroma. Cancer Genet. Cytogenet. 77, 50–54.

    CAS  PubMed  Google Scholar 

  176. Wang, S., Saboorian, M.H., Frenkel, E., Hynan, L., Gokaslan, S.T., and Ashfaq, R. (2000) Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays. J. Clin. Pathol. 53, 374–381.

    CAS  PubMed Central  PubMed  Google Scholar 

  177. Tanner, M., Gancberg, D., Di Leo, A., et al. (2000) Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am. J. Pathol. 157, 1467–1472.

    CAS  PubMed Central  PubMed  Google Scholar 

  178. Zhao, J., Wu, R., Au, A., Marquez, A., Yu, Y., and Shi, Z. (2002) Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Mod. Pathol. 15, 657–665.

    PubMed  Google Scholar 

  179. Vocke, C.D., Pozzatti, R.O., Bostwick, D.G., et al. (1996) Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res. 56, 2411–2416.

    CAS  PubMed  Google Scholar 

  180. Huang, S.F., Xiao, S., Renshaw, A.A., Loughlin, K.R., Hudson, T.J., and Fletcher, J.A. (1996) Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Am. J. Pathol. 149, 1565–1573.

    CAS  PubMed Central  PubMed  Google Scholar 

  181. Cher, M.L., Ito, T., Weidner, N., Carroll, P.R., and Jensen, R.H. (1995) Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J. Urol. 153, 249–254.

    CAS  PubMed  Google Scholar 

  182. Gray, I.C., Phillips, S.M., Lee, S.J., Neoptolemos, J.P., Weissenbach, J., and Spurr, N.K. (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55, 4800–4803.

    CAS  PubMed  Google Scholar 

  183. Matsuyama, H., Pan, Y., Oba, K., et al. (2003) The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer. Aktuelle Urol. 34, 247–249.

    CAS  PubMed  Google Scholar 

  184. Matsuyama, H., Pan, Y., Yoshihiro, S., et al. (2003) Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer. Prostate 54, 103–111.

    CAS  PubMed  Google Scholar 

  185. Nemoto, R., Nakamura, I., Uchida, K., and Harada, M. (1995) Numerical chromosome aberrations in bladder cancer detected by in situ hybridization. Br. J. Urol. 75, 470–476.

    CAS  PubMed  Google Scholar 

  186. Stadler, W.M., Sherman, J., Bohlander, S.K., et al. (1994) Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res. 54, 2060–2063.

    CAS  PubMed  Google Scholar 

  187. Sandberg, A.A. and Berger, C.S. (1994) Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J. Urol. 151, 545–560.

    CAS  PubMed  Google Scholar 

  188. Skacel, M., Fahmy, M., Brainard, J.A., et al. (2003) Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J. Urol. 169, 2101–2105.

    CAS  PubMed  Google Scholar 

  189. Stadler, W.M., Steinberg, G., Yang, X., Hagos, F., Turner, C., and Olopade, O.I. (2001) Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. Clin. Cancer Res. 7, 1676–1682.

    CAS  PubMed  Google Scholar 

  190. Anonymous (1988) Occupational bladder cancer: a guide for clinicians. The BAUS Subcommittee on Industrial Bladder Cancer. Br. J. Urol. 61, 183–191.

    Google Scholar 

  191. Schulte, P.A., Ringen, K., Hemstreet, G.P., Aet al. (1986) Risk factors for bladder cancer in a cohort exposed to aromatic amines. Cancer 58, 2156–2162.

    CAS  PubMed  Google Scholar 

  192. Hartge, P., Hoover, R., and Kantor, A. (1985) Bladder cancer risk and pipes, cigars, and smokeless tobacco. Cancer 55, 901–906.

    CAS  PubMed  Google Scholar 

  193. El-Bolkainy, M.N., Mokhtar, N.M., Ghoneim, M.A., and Hussein, M.H. (1981) The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 48, 2643–2648.

    CAS  PubMed  Google Scholar 

  194. Reifenberger, G. and Louis, D.N. (2003) Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J. Neuropathol. Exp. Neurol. 62, 111–126.

    CAS  PubMed  Google Scholar 

  195. Ino, Y., Betensky, R.A., Zlatescu, M.C., et al. (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7, 839–845.

    CAS  PubMed  Google Scholar 

  196. Eller, J.L., Longo, S.L., Hicklin, D.J., and Canute, G.W. (2002) Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. Neurosurgery 51, 1005–1013.

    PubMed  Google Scholar 

  197. Bosl, G.J., Ilson, D.H., Rodriguez, E., Motzer, R.J., Reuter, V.E., and Chaganti, R.S. (1994) Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J. Natl. Cancer Inst. 86, 349–355.

    CAS  PubMed  Google Scholar 

  198. Mertens, F., Johansson, B., and Mitelman, F. (1994) Isochromosomes in neoplasia. Genes Chromosomes Cancer 10, 221–230.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Brigham and Women’s Hospital, Boston, MA

    Jonathan A. Fletcher MD

Authors
  1. Jonathan A. Fletcher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. AmeriPath Inc., USA

    Steven L. Gersen PhD

  2. School of Allied Health Professions, University of Connecticut, Storrs, CT

    Martha B. Keagle MEd

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Fletcher, J.A. (2005). Cytogenetics of Solid Tumors. In: Gersen, S.L., Keagle, M.B. (eds) The Principles of Clinical Cytogenetics. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-833-1:421

Download citation

Publish with us

Policies and ethics

Search

Navigation